of the celsr3 promoter (
al. 2007
2011
Hospital Oakland Research Institute (
zH42M24T7 on the Sanger Welcome Trust web site. Briefly, PCR was performed to
create a fragment containing EGFP and the kanamycin resistance gene flanked by
LoxP sites. Engineered on either side of this construct were domains containing
homology to celsr3 exon1 in the BAC. This was done using
primers forward (GGATTTCACTAGACTAATGGTGAGCAAGGGCGAGGAG) and reverse
(CTTGCTCACCATTAGTCTAGTGAAATCCTTTCTCTCTC). Bacteria containing the BAC were
electroporated with the fragment and then recombination was induced and selected
for by kanamycin resistance. Colonies that were kanamycin resistant were grown
and prepped using an Invitrogen Midi prep kit according to manufacturer
instructions, except that DNA was pipetted a minimum number of times to avoid
shearing. Colonies were checked by PCR and sequencing. After EGFP insertion was
confirmed, the DNA was treated with Cre recombinase to remove the kanamycin
resistance gene. The final DNA product was then re-electroporated into
Bacteria.